23h
GlobalData on MSNAllurion’s weight loss balloon back on French marketAllurion’s CEO confirmed to Medical Device Network that the company has changed advertising, patient follow-up, and physician ...
Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...
21h
Futurism on MSNEvidence Is Growing That Ozempic Can Cause BlindnessAs drugs like Ozempic and Mounjaro continue to skyrocket in usage, doctors are encountering more cases linking them to ...
Find out if it's safe to drink alcohol during your Ozempic treatment, whether alcohol raises the risk of any sides effects, ...
21h
HealthDay on MSNSenators Call on FDA to Act Against Misleading Weight-Loss Drug CommercialsLawmakers are calling out advertisement of prescription of injectable weight-loss drugs without disclosing safety and risk information.
20h
Fin vs Fin on MSNZealthy vs Ro: Which Weight Loss Plan Works Best?Zealthy and Ro both offer FDA-approved, generic GLP-1s at personalized dosages to fit your needs. These platforms also have a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results